Literature DB >> 22893695

Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia.

Anne Bachelot1, Zeina Chakhtoura, Geneviève Plu-Bureau, Mathieu Coudert, Christiane Coussieu, Yasmina Badachi, Jérome Dulon, Beny Charbit, Philippe Touraine.   

Abstract

OBJECTIVE: Women with classical congenital adrenal hyperplasia (CAH) exhibit reduced fertility due to several factors including anovulation. This has been attributed to a disturbed gonadotropic axis as in polycystic ovary syndrome (PCOS), but there is no precise evaluation. Our aim was to evaluate the gonadotropic axis and LH pulsatility patterns and to determine factor(s) that could account for the potential abnormality of LH pulsatility.
DESIGN: Case/control study.
METHODS: Sixteen CAH women (11 with the salt-wasting form and five with the simple virilizing form), aged from 18 to 40 years, and 16 age-matched women, with regular menstrual cycles (28 ± 3 days), were included. LH pulse patterns over 6 h were determined in patients and controls.
RESULTS: No differences were observed between patients and controls in terms of mean LH levels, LH pulse amplitude, or LH frequency. In CAH patients, LH pulsatility patterns were heterogeneous, leading us to perform a clustering analysis of LH data, resulting in a two-cluster partition. Patients in cluster 1 had similar LH pulsatility patterns to the controls. Patients in cluster 2 had: lower LH pulse amplitude and frequency and presented menstrual cycle disturbances more frequently; higher 17-OH progesterone, testosterone, progesterone, and androstenedione levels; and lower FSH levels.
CONCLUSIONS: LH pulsatility may be normal in CAH women well controlled by hormonal treatment. Undertreatment is responsible for hypogonadotropic hypogonadism, with low LH pulse levels and frequency, but not PCOS. Suppression of progesterone and androgen concentrations during the follicular phase of the menstrual cycle should be a major objective in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893695     DOI: 10.1530/EJE-12-0454

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

Review 1.  Neuroendocrine causes of amenorrhea--an update.

Authors:  Lindsay T Fourman; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-12       Impact factor: 5.958

Review 2.  Congenital Adrenal Hyperplasia.

Authors:  Selma Feldman Witchel
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-04-24       Impact factor: 1.814

3.  Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency.

Authors:  Dong Ho Lee; Sung Hye Kong; Han Na Jang; Chang Ho Ahn; Seung Gyun Lim; Young Ah Lee; Sang Wan Kim; Jung Hee Kim
Journal:  Arch Osteoporos       Date:  2022-03-08       Impact factor: 2.617

4.  Congenital adrenal hyperplasia and pregnancy.

Authors:  Soulmaz Shorakae; Helena Teede
Journal:  BMJ Case Rep       Date:  2013-08-05

5.  Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors:  Seung Gyun Lim; Young Ah Lee; Han Na Jang; Sung Hye Kong; Chang Ho Ahn; Sang Wan Kim; Choong Ho Shin; Jung Hee Kim
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-12       Impact factor: 5.555

6.  Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.

Authors:  Miguel Debono; Ashwini Mallappa; Verena Gounden; Aikaterini A Nella; Robert F Harrison; Christopher A Crutchfield; Peter S Backlund; Steven J Soldin; Richard J Ross; Deborah P Merke
Journal:  Eur J Endocrinol       Date:  2015-09-04       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.